HomeGALT • NASDAQ
add
Galectin Therapeutics Inc. Common Stock
Previous close
$3.06
Day range
$2.99 - $3.55
Year range
$1.28 - $4.27
Market cap
210.61M USD
Avg Volume
233.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.56M | -10.08% |
Net income | -10.00M | 5.99% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 25.66M | 38.02% |
Total assets | 28.20M | 32.49% |
Total liabilities | 88.44M | 65.38% |
Total equity | -60.24M | — |
Shares outstanding | 61.90M | — |
Price to book | -3.03 | — |
Return on assets | -94.92% | — |
Return on capital | -205.60% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -10.00M | 5.99% |
Cash from operations | -4.70M | 35.05% |
Cash from investing | — | — |
Cash from financing | 10.00M | 0.00% |
Net change in cash | 5.30M | 91.89% |
Free cash flow | -1.65M | 51.50% |
About
Founded
2000
Headquarters
Website
Employees
14